Infectious Disease Molecular Diagnostics Market by Technology, Product Type, Application, End User & Region | Forecast 2022 to 2032
With the Covid-19 outbreak, a sudden spurt in demand for infectious disease molecular diagnostics was observed- Significant opportunities projected post-pandemic
Infectious Disease Molecular Diagnostics Market Outlook (2022 to 2032)
The global Infectious Disease Molecular Diagnostics Market was valued at around US$ 34 billion in 2021. With a projected CAGR of 4.2% for the next ten years, the market is likely to reach a valuation of nearly US$ 53 billion by the end of 2032. Developers are increasingly relying on scientific developments from a variety of fields rather than the traditional methods that required the culture of the pathogens. Molecular diagnostics is one of the fields in infectious Disease identification that is expanding the fastest.
Customize your report by selecting specific countries or regions and save 30%!
Sales Analysis of Infectious Disease Infectious Disease Molecular Diagnostics Market from 2017 to 2021 Vs Market Outlook for 2022 to 2032
The global market for the Infectious Disease Molecular Diagnostics Market expanded at a CAGR of 3.8% over the last four years (2017 to 2021). Future Market Insights’ analysis reveals that in 2022 revenue through the market is estimated at US$ 39.5 billion. With an absolute dollar opportunity of US$ 18 billion from 2022 to 2032, the market is projected to reach a valuation of US$ 53 billion by 2032.
The USA will continue to be the largest consumer of the Infectious Disease Molecular Diagnostics Market throughout the analysis period accounting for over US$ 5.8 billion absolute dollar opportunity in the coming 10-year period
What are the key drivers in Infectious Disease Molecular Diagnostics Market?
Global outbreaks of deadly infectious diseases caused by pathogenic microorganisms have threatened public health worldwide and significantly motivated researchers to develop rapid and accurate detection methods for pathogens. Culture-based techniques are considered gold standards for pathogen detection globally. However, the long result time associated with these techniques due to overnight culturing and limited pathogen isolation has slowed their demand to a certain extent. Over the past several years, innovations in molecular diagnostic technology and their use have fundamentally altered the ability to handle infectious diseases. It provides quicker and more reliable results at 30% less cost to the customers.
Although still in its infancy, pharmacogenomics has the potential to grow into a rich industry as demand for tailored medication rises. As the driving force behind the transition to personalized medicine, many pharmaceutical companies are assessing revenue models based on molecular diagnostics for pharmacogenomics testing.
Find your sweet spots for generating winning opportunities in this market.
What are the restraints to the growth of the Infectious Disease Molecular Diagnostics Market?
One of the key factors limiting the growth of the infectious disease molecular diagnostics market is inadequate reimbursements. The hurdles to getting Medicare insurance to pay for diagnostic tests are a significant concern for diagnostic organizations. In 2018, Medicare in the USA tightened constraints on I.V.D. diagnostic claims, which affected molecular diagnostic tests in particular. These molecular pathology tests might be billed using unlisted medical codes rather than the American Medical Association's Current Procedural Terminology (CPT) numbers. Medicare Administrative Contractors (MACs) set the allowable cost amount for the billing locality in these cases.
The entirety of the clinical lab will gradually be expected to execute molecular diagnostics testing on a regular basis. Venture capitalists, who formerly preferred not to make investments in this area, will progressively grow more enthusiastic about investing in molecular diagnostic businesses as the field of molecular diagnostics progresses.
Region-wise Insights
In what ways does the Infectious Disease Molecular Diagnostics Market in North America have a bright future?
The American Cancer Society estimates that there will be 1.7 million new instances of cancer in the US this year and more than 606 thousand cancer-related deaths. Therefore, it is predicted that over the forecast period, the demand for molecular diagnostics would expand due to the rising incidence of cancer and increased public awareness of the importance of early cancer detection. The development and global distribution agreement for molecular testing in Mexico to find new sexually-transmitted infections were announced by Becton Dickinson and Euroclone in February 2019. The market is projected to expand in the future due to rising diseases and innovation in North America.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Country-wise Insights
United States Infectious Disease Molecular Diagnostics Market Analysis
The USA will account for over US$ 16.9 billion of the global market by 2032. 6 out of 10 of America's adults have a chronic disease, and 4 out of 10 people have two or more diseases. , as of January 2021, according to a report made public by the National Center for Chronic Disease Prevention and Health Promotion. The US FDA had received emergency use authorization requests from Becton, Dickinson, and Company, and BioGX Inc. for novel diagnostic tests, the two businesses announced in March 2020.
UK Infectious Disease Molecular Diagnostics Market Analysis
The market in the UK is expected to reach US$ 2.2 billion, growing from US$ 1.5 billion in 2021. The market in the country is projected to expand at a CAGR of 3.5% from 2022 to 2032, and prosper with an absolute dollar opportunity of US$ 644 million.
Japan Infectious Disease Molecular Diagnostics Market Analysis
The market in Japan is expected to gross an absolute dollar opportunity of US$ 981 million from 2022 to 2032. During this period, the market is projected to register a CAGR of 5.9% to reach a market size of US$ 2.3 billion by 2032.
South Korea Infectious Disease Molecular Diagnostics Market Analysis
The market in South Korea is expected to gross an absolute dollar opportunity of US$ 400 million from 2022 to 2032. The market is likely to reach a valuation of US$ 1.1 billion by 2032.
The Polymerase Chain Reaction (PCR) segment account for over 30% of the technology category of the global Infectious Disease Molecular Diagnostics Market. The market growth from 2017 to 2021 was estimated at 4.4% CAGR. A qualitative outcome of a PCR investigation may be required for the detection of genetic polymorphisms, inherited disorders, somatic mutations, including cancer, and the presence of viral or microbial infections.
Quantitative PCR is increasingly needed, for instance, to assess a pathogen's titer, the quantity of infected or altered cells in a tissue, and the concentration of particular mRNAs. PCR has several uses in medicine, including tissue typing for organ and tissue transplants. Commercially, HLA DQa locus analysis kits are currently readily available. The application of PCR for forensic purposes is associated with this application. The PCR can use this area, in particular, to take advantage of its extreme sensitivity.
Competitive Landscape
At present, many diagnostics firms that were under-represented in this area have sought partners or acquisitions to gain exposure, reflecting the growing interest in personalized medicine. The key companies operating in the market include F. Hoffmann-La Roche Ltd., Hologic, Inc., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Abbott Laboratories, bioMérieux SA, QIAGEN N.V., Myriad Genetics, Inc., Siemens Healthineers AG, Danaher Corporation, Illumina, Inc., Becton Dickinson and Company, Grifols, S.A., Quidel Corporation, Agilent Technologies, Inc., DiaSorin S.p.a. (Italy), Exact Sciences Corporation, Genetic Signatures, MDx Health, Biocartis NV, TBG Diagnostics Limited, HTG Molecular Diagnostics, Inc., Vela Diagnostics, Amoy Diagnostics Co., Ltd., ELITechGroup, Molbio Diagnostics Pvt. Ltd., Savyon Diagnostics, Abacus Diagnostica Oy, and geneOmbio Technologies Pvt. Ltd.
Some of the recent developments by key providers of Infectious Disease Molecular Diagnostics are as follows:
InSeptember 2021, F. Hoffmann-La Roche Ltd. announced the acquisition of TIB Molbiol to increase the breadth of infectious illness assays in its PCR test line.
InJune 2021 Verogen and QIAGEN N.V. collaborated to increase the range of NGS technologies available.
InJune 2021, Mobidiag Oy, a provider of acute care molecular diagnostic testing, was purchased by Hologic, Inc. The product offering for molecular diagnostics at Hologic will be boosted by this acquisition.
InNovember 2020, an additional FDA approval was given to Hologic, Inc. for the AptimaHIV-1 Quant Dx Assay's use in assisting with HIV infection diagnosis.
Similarly, recent developments related to companies manufacturing infectious disease molecular diagnostics kits have been tracked by the team at Future Market Insights, which is available in the full report.
Key Segments Covered in Infectious Disease Molecular Diagnostics Market Survey
How much is the global Infectious Disease Molecular Diagnostics Market currently worth?
The global Infectious Disease Molecular Diagnostics Market was valued at US$ 34 billion in 2021.
What is the Infectious Disease Molecular Diagnostics Market Forecast through 2032?
The Infectious Disease Infectious Disease Molecular Diagnostics Market is set to witness a growth rate of 4.2% over the forecast period and be valued at US$ 53 billion by 2032.
At what rate did demand for the Infectious Disease Molecular Diagnostics Market increase over the past 4 years?
The Infectious Disease Infectious Disease Molecular Diagnostics Market expanded by 3.7% from 2017 through 2021.
Who are the key players shaping the Infectious Disease Molecular Diagnostics Market?
The key players BD, BioMérieux SA, Bio-Rad Laboratories Inc., Abbott, and Agilent Technologies Inc. are shaping the Infectious Disease Molecular Diagnostics Market.
Which are the top 5 countries driving the highest sales in the Infectious Disease Molecular Diagnostics Market?
United States, United Kingdom, China, Japan, and South Korea are expected to drive the most sales growth in the Infectious Disease Molecular Diagnostics Market.
Table of Content
1. Executive Summary | Infectious Disease Molecular Diagnostics Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. Value Chain Analysis
3.5.1. Profit Margin Analysis
3.5.2. Service Providers
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ billion) Analysis, 2017 to 2021
4.2. Current and Future Market Size Value (US$ billion) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ billion) Analysis By Application, 2017 to 2021
5.3. Current and Future Market Size Value (US$ billion) Analysis and Forecast By Application, 2022 to 2032
5.3.1. Oncology
5.3.1.1. Breast Cancer
5.3.1.2. Prostate Cancer
5.3.1.3. Colorectal Cancer
5.3.1.4. Cervical Cancer
5.3.1.5. Kidney Cancer
5.3.1.6. Liver Cancer
5.3.1.7. Blood Cancer
5.3.1.8. Lung Cancer
5.3.1.9. Other Cancer
5.3.2. Infectious Diseases
5.3.2.1. Methicillin-resistant Staphylococcus Aureus (MRSA)
5.3.2.2. Clostridium Difficile
5.3.2.3. Vancomycin-resistant Enterococci (VRE)
5.3.2.4. Carbapenem-resistant Bacteria
5.3.2.5. Other Infectious Diseases
5.3.3. Genetic Testing
5.3.3.1. Newborn Screening
5.3.3.2. Predictive and Presymptomatic Testing
5.3.3.3. Other Genetic Testing
5.3.4. Pharmacogenomics
5.3.5. Neurological Disease
5.3.6. Cardiovascular Disease
5.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2021
5.5. Absolute $ Opportunity Analysis By Application, 2022 to 2032
6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ billion) Analysis By Product Type, 2017 to 2021
6.3. Current and Future Market Size Value (US$ billion) Analysis and Forecast By Product Type, 2022 to 2032
6.3.1. Instruments
6.3.2. Reagents
6.3.3. Other Product Types
6.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2021
6.5. Absolute $ Opportunity Analysis By Product Type, 2022 to 2032
7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Test Location
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ billion) Analysis By Test Location, 2017 to 2021
7.3. Current and Future Market Size Value (US$ billion) Analysis and Forecast By Test Location, 2022 to 2032
7.3.1. Point-of-Care
7.3.2. Self-test or Over the Counter
7.3.3. Central Laboratories
7.4. Y-o-Y Growth Trend Analysis By Test Location, 2017 to 2021
7.5. Absolute $ Opportunity Analysis By Test Location, 2022 to 2032
8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Technology
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ billion) Analysis By Technology, 2017 to 2021
8.3. Current and Future Market Size Value (US$ billion) Analysis and Forecast By Technology, 2022 to 2032
8.3.1. Polymerase Chain Reaction (PCR)
8.3.2. In Situ Hybridization (ISH)
8.3.3. Isothermal Nucleic Acid Amplification Technology (INAAT)
8.3.4. Chips and Microarrays
8.3.5. Mass Spectrometry
8.3.6. Sequencing
8.3.7. Transcription Mediated Amplification (TMA)
8.3.8. Other Technologies
8.4. Y-o-Y Growth Trend Analysis By Technology, 2017 to 2021
8.5. Absolute $ Opportunity Analysis By Technology, 2022 to 2032
9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ billion) Analysis By Region, 2017 to 2021
9.3. Current Market Size Value (US$ billion) Analysis and Forecast By Region, 2022 to 2032
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Asia Pacific
9.3.5. Middle East and Africa (MEA)
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ billion) Trend Analysis By Market Taxonomy, 2017 to 2021
10.2. Market Size Value (US$ billion) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. United States of America
10.2.1.2. Canada
10.2.2. By Application
10.2.3. By Product Type
10.2.4. By Test Location
10.2.5. By Technology
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Application
10.3.3. By Product Type
10.3.4. By Test Location
10.3.5. By Technology
10.4. Key Takeaways
11. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ billion) Trend Analysis By Market Taxonomy, 2017 to 2021
11.2. Market Size Value (US$ billion) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Application
11.2.3. By Product Type
11.2.4. By Test Location
11.2.5. By Technology
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Application
11.3.3. By Product Type
11.3.4. By Test Location
11.3.5. By Technology
11.4. Key Takeaways
12. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ billion) Trend Analysis By Market Taxonomy, 2017 to 2021
12.2. Market Size Value (US$ billion) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. Italy
12.2.1.3. France
12.2.1.4. United Kingdom
12.2.1.5. Spain
12.2.1.6. Russia
12.2.1.7. Rest of Europe
12.2.2. By Application
12.2.3. By Product Type
12.2.4. By Test Location
12.2.5. By Technology
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Application
12.3.3. By Product Type
12.3.4. By Test Location
12.3.5. By Technology
12.4. Key Takeaways
13. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
13.1. Historical Market Size Value (US$ billion) Trend Analysis By Market Taxonomy, 2017 to 2021
13.2. Market Size Value (US$ billion) Forecast By Market Taxonomy, 2022 to 2032
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. India
13.2.1.4. South Korea
13.2.1.5. Australia
13.2.1.6. Rest of APAC
13.2.2. By Application
13.2.3. By Product Type
13.2.4. By Test Location
13.2.5. By Technology
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Application
13.3.3. By Product Type
13.3.4. By Test Location
13.3.5. By Technology
13.4. Key Takeaways
14. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
14.1. Historical Market Size Value (US$ billion) Trend Analysis By Market Taxonomy, 2017 to 2021
14.2. Market Size Value (US$ billion) Forecast By Market Taxonomy, 2022 to 2032
14.2.1. By Country
14.2.1.1. South Africa
14.2.1.2. Saudi Arabia
14.2.1.3. UAE
14.2.1.4. Israel
14.2.1.5. Rest of MEA
14.2.2. By Application
14.2.3. By Product Type
14.2.4. By Test Location
14.2.5. By Technology
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Application
14.3.3. By Product Type
14.3.4. By Test Location
14.3.5. By Technology
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. United States of America
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Application
15.1.2.2. By Product Type
15.1.2.3. By Test Location
15.1.2.4. By Technology
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Application
15.2.2.2. By Product Type
15.2.2.3. By Test Location
15.2.2.4. By Technology
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Application
15.3.2.2. By Product Type
15.3.2.3. By Test Location
15.3.2.4. By Technology
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Application
15.4.2.2. By Product Type
15.4.2.3. By Test Location
15.4.2.4. By Technology
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Application
15.5.2.2. By Product Type
15.5.2.3. By Test Location
15.5.2.4. By Technology
15.6. Italy
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2021
15.6.2.1. By Application
15.6.2.2. By Product Type
15.6.2.3. By Test Location
15.6.2.4. By Technology
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2021
15.7.2.1. By Application
15.7.2.2. By Product Type
15.7.2.3. By Test Location
15.7.2.4. By Technology
15.8. United Kingdom
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2021
15.8.2.1. By Application
15.8.2.2. By Product Type
15.8.2.3. By Test Location
15.8.2.4. By Technology
15.9. Spain
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2021
15.9.2.1. By Application
15.9.2.2. By Product Type
15.9.2.3. By Test Location
15.9.2.4. By Technology
15.10. Russia
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2021
15.10.2.1. By Application
15.10.2.2. By Product Type
15.10.2.3. By Test Location
15.10.2.4. By Technology
15.11. China
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2021
15.11.2.1. By Application
15.11.2.2. By Product Type
15.11.2.3. By Test Location
15.11.2.4. By Technology
15.12. Japan
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2021
15.12.2.1. By Application
15.12.2.2. By Product Type
15.12.2.3. By Test Location
15.12.2.4. By Technology
15.13. India
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2021
15.13.2.1. By Application
15.13.2.2. By Product Type
15.13.2.3. By Test Location
15.13.2.4. By Technology
15.14. South Korea
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2021
15.14.2.1. By Application
15.14.2.2. By Product Type
15.14.2.3. By Test Location
15.14.2.4. By Technology
15.15. Australia
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2021
15.15.2.1. By Application
15.15.2.2. By Product Type
15.15.2.3. By Test Location
15.15.2.4. By Technology
15.16. South Africa
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2021
15.16.2.1. By Application
15.16.2.2. By Product Type
15.16.2.3. By Test Location
15.16.2.4. By Technology
15.17. Saudi Arabia
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2021
15.17.2.1. By Application
15.17.2.2. By Product Type
15.17.2.3. By Test Location
15.17.2.4. By Technology
15.18. UAE
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2021
15.18.2.1. By Application
15.18.2.2. By Product Type
15.18.2.3. By Test Location
15.18.2.4. By Technology
15.19. Israel
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2021
15.19.2.1. By Application
15.19.2.2. By Product Type
15.19.2.3. By Test Location
15.19.2.4. By Technology
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Application
16.3.3. By Product Type
16.3.4. By Test Location
16.3.5. By Technology
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. BD
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. BioMérieux SA
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Bio-Rad Laboratories Inc
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. Abbott
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Agilent Technologies, Inc.
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. Danaher
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. Hologic Inc
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. IlluminaInc
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. Johnson & Johnson Services Inc
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. GrifolsS.A.
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
17.1.11. QIAGEN
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.11.5.2. Product Strategy
17.1.11.5.3. Channel Strategy
17.1.12. F. Hoffmann-La RocheLtd
17.1.12.1. Overview
17.1.12.2. Product Portfolio
17.1.12.3. Profitability by Market Segments
17.1.12.4. Sales Footprint
17.1.12.5. Strategy Overview
17.1.12.5.1. Marketing Strategy
17.1.12.5.2. Product Strategy
17.1.12.5.3. Channel Strategy
17.1.13. Siemens Healthineers AG
17.1.13.1. Overview
17.1.13.2. Product Portfolio
17.1.13.3. Profitability by Market Segments
17.1.13.4. Sales Footprint
17.1.13.5. Strategy Overview
17.1.13.5.1. Marketing Strategy
17.1.13.5.2. Product Strategy
17.1.13.5.3. Channel Strategy
18. Assumptions & Acronyms Used19. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ billion) Forecast by Region, 2017 to 2032
Table 2: Global Market Value (US$ billion) Forecast by Application, 2017 to 2032
Table 3: Global Market Value (US$ billion) Forecast by Product Type, 2017 to 2032
Table 4: Global Market Value (US$ billion) Forecast by Test Location, 2017 to 2032
Table 5: Global Market Value (US$ billion) Forecast by Technology, 2017 to 2032
Table 6: North America Market Value (US$ billion) Forecast by Country, 2017 to 2032
Table 7: North America Market Value (US$ billion) Forecast by Application, 2017 to 2032
Table 8: North America Market Value (US$ billion) Forecast by Product Type, 2017 to 2032
Table 9: North America Market Value (US$ billion) Forecast by Test Location, 2017 to 2032
Table 10: North America Market Value (US$ billion) Forecast by Technology, 2017 to 2032
Table 11: Latin America Market Value (US$ billion) Forecast by Country, 2017 to 2032
Table 12: Latin America Market Value (US$ billion) Forecast by Application, 2017 to 2032
Table 13: Latin America Market Value (US$ billion) Forecast by Product Type, 2017 to 2032
Table 14: Latin America Market Value (US$ billion) Forecast by Test Location, 2017 to 2032
Table 15: Latin America Market Value (US$ billion) Forecast by Technology, 2017 to 2032
Table 16: Europe Market Value (US$ billion) Forecast by Country, 2017 to 2032
Table 17: Europe Market Value (US$ billion) Forecast by Application, 2017 to 2032
Table 18: Europe Market Value (US$ billion) Forecast by Product Type, 2017 to 2032
Table 19: Europe Market Value (US$ billion) Forecast by Test Location, 2017 to 2032
Table 20: Europe Market Value (US$ billion) Forecast by Technology, 2017 to 2032
Table 21: Asia Pacific Market Value (US$ billion) Forecast by Country, 2017 to 2032
Table 22: Asia Pacific Market Value (US$ billion) Forecast by Application, 2017 to 2032
Table 23: Asia Pacific Market Value (US$ billion) Forecast by Product Type, 2017 to 2032
Table 24: Asia Pacific Market Value (US$ billion) Forecast by Test Location, 2017 to 2032
Table 25: Asia Pacific Market Value (US$ billion) Forecast by Technology, 2017 to 2032
Table 26: MEA Market Value (US$ billion) Forecast by Country, 2017 to 2032
Table 27: MEA Market Value (US$ billion) Forecast by Application, 2017 to 2032
Table 28: MEA Market Value (US$ billion) Forecast by Product Type, 2017 to 2032
Table 29: MEA Market Value (US$ billion) Forecast by Test Location, 2017 to 2032
Table 30: MEA Market Value (US$ billion) Forecast by Technology, 2017 to 2032
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ billion) by Application, 2022 to 2032
Figure 2: Global Market Value (US$ billion) by Product Type, 2022 to 2032
Figure 3: Global Market Value (US$ billion) by Test Location, 2022 to 2032
Figure 4: Global Market Value (US$ billion) by Technology, 2022 to 2032
Figure 5: Global Market Value (US$ billion) by Region, 2022 to 2032
Figure 6: Global Market Value (US$ billion) Analysis by Region, 2017 to 2032
Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032
Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032
Figure 9: Global Market Value (US$ billion) Analysis by Application, 2017 to 2032
Figure 10: Global Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 11: Global Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 12: Global Market Value (US$ billion) Analysis by Product Type, 2017 to 2032
Figure 13: Global Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 14: Global Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 15: Global Market Value (US$ billion) Analysis by Test Location, 2017 to 2032
Figure 16: Global Market Value Share (%) and BPS Analysis by Test Location, 2022 to 2032
Figure 17: Global Market Y-o-Y Growth (%) Projections by Test Location, 2022 to 2032
Figure 18: Global Market Value (US$ billion) Analysis by Technology, 2017 to 2032
Figure 19: Global Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 20: Global Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 21: Global Market Attractiveness by Application, 2022 to 2032
Figure 22: Global Market Attractiveness by Product Type, 2022 to 2032
Figure 23: Global Market Attractiveness by Test Location, 2022 to 2032
Figure 24: Global Market Attractiveness by Technology, 2022 to 2032
Figure 25: Global Market Attractiveness by Region, 2022 to 2032
Figure 26: North America Market Value (US$ billion) by Application, 2022 to 2032
Figure 27: North America Market Value (US$ billion) by Product Type, 2022 to 2032
Figure 28: North America Market Value (US$ billion) by Test Location, 2022 to 2032
Figure 29: North America Market Value (US$ billion) by Technology, 2022 to 2032
Figure 30: North America Market Value (US$ billion) by Country, 2022 to 2032
Figure 31: North America Market Value (US$ billion) Analysis by Country, 2017 to 2032
Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 34: North America Market Value (US$ billion) Analysis by Application, 2017 to 2032
Figure 35: North America Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 36: North America Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 37: North America Market Value (US$ billion) Analysis by Product Type, 2017 to 2032
Figure 38: North America Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 39: North America Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 40: North America Market Value (US$ billion) Analysis by Test Location, 2017 to 2032
Figure 41: North America Market Value Share (%) and BPS Analysis by Test Location, 2022 to 2032
Figure 42: North America Market Y-o-Y Growth (%) Projections by Test Location, 2022 to 2032
Figure 43: North America Market Value (US$ billion) Analysis by Technology, 2017 to 2032
Figure 44: North America Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 45: North America Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 46: North America Market Attractiveness by Application, 2022 to 2032
Figure 47: North America Market Attractiveness by Product Type, 2022 to 2032
Figure 48: North America Market Attractiveness by Test Location, 2022 to 2032
Figure 49: North America Market Attractiveness by Technology, 2022 to 2032
Figure 50: North America Market Attractiveness by Country, 2022 to 2032
Figure 51: Latin America Market Value (US$ billion) by Application, 2022 to 2032
Figure 52: Latin America Market Value (US$ billion) by Product Type, 2022 to 2032
Figure 53: Latin America Market Value (US$ billion) by Test Location, 2022 to 2032
Figure 54: Latin America Market Value (US$ billion) by Technology, 2022 to 2032
Figure 55: Latin America Market Value (US$ billion) by Country, 2022 to 2032
Figure 56: Latin America Market Value (US$ billion) Analysis by Country, 2017 to 2032
Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 59: Latin America Market Value (US$ billion) Analysis by Application, 2017 to 2032
Figure 60: Latin America Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 62: Latin America Market Value (US$ billion) Analysis by Product Type, 2017 to 2032
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 65: Latin America Market Value (US$ billion) Analysis by Test Location, 2017 to 2032
Figure 66: Latin America Market Value Share (%) and BPS Analysis by Test Location, 2022 to 2032
Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Test Location, 2022 to 2032
Figure 68: Latin America Market Value (US$ billion) Analysis by Technology, 2017 to 2032
Figure 69: Latin America Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 70: Latin America Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 71: Latin America Market Attractiveness by Application, 2022 to 2032
Figure 72: Latin America Market Attractiveness by Product Type, 2022 to 2032
Figure 73: Latin America Market Attractiveness by Test Location, 2022 to 2032
Figure 74: Latin America Market Attractiveness by Technology, 2022 to 2032
Figure 75: Latin America Market Attractiveness by Country, 2022 to 2032
Figure 76: Europe Market Value (US$ billion) by Application, 2022 to 2032
Figure 77: Europe Market Value (US$ billion) by Product Type, 2022 to 2032
Figure 78: Europe Market Value (US$ billion) by Test Location, 2022 to 2032
Figure 79: Europe Market Value (US$ billion) by Technology, 2022 to 2032
Figure 80: Europe Market Value (US$ billion) by Country, 2022 to 2032
Figure 81: Europe Market Value (US$ billion) Analysis by Country, 2017 to 2032
Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 84: Europe Market Value (US$ billion) Analysis by Application, 2017 to 2032
Figure 85: Europe Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 86: Europe Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 87: Europe Market Value (US$ billion) Analysis by Product Type, 2017 to 2032
Figure 88: Europe Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 89: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 90: Europe Market Value (US$ billion) Analysis by Test Location, 2017 to 2032
Figure 91: Europe Market Value Share (%) and BPS Analysis by Test Location, 2022 to 2032
Figure 92: Europe Market Y-o-Y Growth (%) Projections by Test Location, 2022 to 2032
Figure 93: Europe Market Value (US$ billion) Analysis by Technology, 2017 to 2032
Figure 94: Europe Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 95: Europe Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 96: Europe Market Attractiveness by Application, 2022 to 2032
Figure 97: Europe Market Attractiveness by Product Type, 2022 to 2032
Figure 98: Europe Market Attractiveness by Test Location, 2022 to 2032
Figure 99: Europe Market Attractiveness by Technology, 2022 to 2032
Figure 100: Europe Market Attractiveness by Country, 2022 to 2032
Figure 101: Asia Pacific Market Value (US$ billion) by Application, 2022 to 2032
Figure 102: Asia Pacific Market Value (US$ billion) by Product Type, 2022 to 2032
Figure 103: Asia Pacific Market Value (US$ billion) by Test Location, 2022 to 2032
Figure 104: Asia Pacific Market Value (US$ billion) by Technology, 2022 to 2032
Figure 105: Asia Pacific Market Value (US$ billion) by Country, 2022 to 2032
Figure 106: Asia Pacific Market Value (US$ billion) Analysis by Country, 2017 to 2032
Figure 107: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 108: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 109: Asia Pacific Market Value (US$ billion) Analysis by Application, 2017 to 2032
Figure 110: Asia Pacific Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 111: Asia Pacific Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 112: Asia Pacific Market Value (US$ billion) Analysis by Product Type, 2017 to 2032
Figure 113: Asia Pacific Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 114: Asia Pacific Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 115: Asia Pacific Market Value (US$ billion) Analysis by Test Location, 2017 to 2032
Figure 116: Asia Pacific Market Value Share (%) and BPS Analysis by Test Location, 2022 to 2032
Figure 117: Asia Pacific Market Y-o-Y Growth (%) Projections by Test Location, 2022 to 2032
Figure 118: Asia Pacific Market Value (US$ billion) Analysis by Technology, 2017 to 2032
Figure 119: Asia Pacific Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 120: Asia Pacific Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 121: Asia Pacific Market Attractiveness by Application, 2022 to 2032
Figure 122: Asia Pacific Market Attractiveness by Product Type, 2022 to 2032
Figure 123: Asia Pacific Market Attractiveness by Test Location, 2022 to 2032
Figure 124: Asia Pacific Market Attractiveness by Technology, 2022 to 2032
Figure 125: Asia Pacific Market Attractiveness by Country, 2022 to 2032
Figure 126: MEA Market Value (US$ billion) by Application, 2022 to 2032
Figure 127: MEA Market Value (US$ billion) by Product Type, 2022 to 2032
Figure 128: MEA Market Value (US$ billion) by Test Location, 2022 to 2032
Figure 129: MEA Market Value (US$ billion) by Technology, 2022 to 2032
Figure 130: MEA Market Value (US$ billion) by Country, 2022 to 2032
Figure 131: MEA Market Value (US$ billion) Analysis by Country, 2017 to 2032
Figure 132: MEA Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 133: MEA Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 134: MEA Market Value (US$ billion) Analysis by Application, 2017 to 2032
Figure 135: MEA Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 136: MEA Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 137: MEA Market Value (US$ billion) Analysis by Product Type, 2017 to 2032
Figure 138: MEA Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 139: MEA Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 140: MEA Market Value (US$ billion) Analysis by Test Location, 2017 to 2032
Figure 141: MEA Market Value Share (%) and BPS Analysis by Test Location, 2022 to 2032
Figure 142: MEA Market Y-o-Y Growth (%) Projections by Test Location, 2022 to 2032
Figure 143: MEA Market Value (US$ billion) Analysis by Technology, 2017 to 2032
Figure 144: MEA Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 145: MEA Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 146: MEA Market Attractiveness by Application, 2022 to 2032
Figure 147: MEA Market Attractiveness by Product Type, 2022 to 2032
Figure 148: MEA Market Attractiveness by Test Location, 2022 to 2032
Figure 149: MEA Market Attractiveness by Technology, 2022 to 2032
Figure 150: MEA Market Attractiveness by Country, 2022 to 2032
